Back to Trials
NCT07223580PHASE4Recruiting

A Study Of Corticosteroid On Postoperative Pain After Ureteroscopy For Urinary Calculi

Mayo Clinic

Start Date

1/23/2026

Completion Date

12/1/2027

Summary

The purpose of this research is to evaluate if corticosteroid (prednisone) after ureteroscopy and placement of the stent will help alleviate postoperative pain control in addition to other normal postoperative pain medications

Eligibility Criteria

Age Range: 18 years to No maximum

Inclusion Criteria: * Patients who are diagnosed with kidney or ureteral stones confirmed on imaging (CT of the abdomen or pelvis) and who elect for definitive treatment via ureteroscopy with placement of ureteral stent. * Age 18 years or older * Patients of either gender * Patients of all ethnic backgrounds * Cable of giving informed consent * Capable and willing to fulfill the requirements of the study. Exclusion Criteria: * History of chronic pain * Chronic use of opioids or other pain medication (\>12 weeks) * Known allergies to corticosteroids. * Known or suspected pregnancy * Inability to give informed consent or unable to meet requirements of the study for any reason. * Bilateral ureteroscopy * Current Corticosteroid Use * Diabetic patients who are insulin dependent

Interventions

DRUG

Corticosteroid

OTHER

Placebo

Interested in This Trial?

Contact the trial locations directly using the information below to learn more about enrollment.

Expressing interest lets you review the study and consent before we connect you with the research site.

Conditions

UreteroscopyPost Operative Pain

Locations

Mayo Clinic in Arizona

Scottsdale, Arizona 85259

United States